Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04774237
Status:
COMPLETED
Last Update Posted:
2022-10-17
First Post:
2021-02-23
Brief Title:
Safety and Efficacy Study of BRIMOCHOL BRIMOCHOL F and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Sponsor:
Visus Therapeutics
Organization:
Visus Therapeutics
Study Overview
Official Title:
A 3-Dose Multicenter Randomized Double-Masked Crossover Phase 2 Safety and Efficacy Study of BRIMOCHOL Topical Ophthalmic Solution vs BRIMOCHOL F Topical Ophthalmic Solution vs Monotherapy With Carbachol Topical Ophthalmic Solution in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Safety and Efficacy Study of BRIMOCHOL vs BRIMOCHOL F vs Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia
Detailed Description:
A 3-Dose Multicenter Randomized Double-Masked Crossover Phase 2 Safety and Efficacy Study of BRIMOCHOL Topical Ophthalmic Solution vs BRIMOCHOL F Topical Ophthalmic Solution vs Monotherapy with Carbachol Topical Ophthalmic Solution in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None